Peptides on the Table: FDA Steps In on Custom Drug Mixes

The U. S. health watchdog is about to check if some lab-made peptides can be mixed freely in pharmacies. Peptides—tiny protein pieces—are popping up in treatments for everything from sleep troubles to weight loss. Yet most of these mixes skip the usual safety checks. A panel will meet in late July to look at seven peptides currently on a “do-not-use” list. Some big names already back wider access, arguing that patients shouldn’t have to hunt on risky online markets for treatments. But experts warn that without solid research, no one really knows what these mixtures do to the body long-term. Some peptide products, like insulin, are already proven safe, but newer versions sold as shots or powders are still untested. That gap pushes desperate buyers toward unregulated sellers, creating a gray zone that’s hard to police.

Doctors and pharmacies feel stuck between patient demand and the law. Compounding pharmacies—the ones that mix custom drugs—are getting pressure to prepare these formulas, even though federal rules say no. This legal gray area has led to a booming black market where untested blends circulate with little oversight.

Actions